Place of hyperthermic intraperitoneal chemotherapy in the armament against pancreatic adenocarcinoma: A survival, mortality and morbidity systematic review

Pancreatic adenocarcinoma is one of the deadliest types of cancer worldwide, with a 5-year survival rate of 8% despite recent treatment advancements. The present systematic review aimed to investigate the role of hyperthermic intraperitoneal chemotherapy (HIPEC) following surgical resection for panc...

Descripción completa

Detalles Bibliográficos
Autores principales: Larentzakis, Andreas, Anagnostou, Evangelos, Georgiou, Konstantinos, Vrakopoulou, Gavriella-Zoi, Zografos, Constantinos G., Zografos, Georgios C., Toutouzas, Konstantinos G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882886/
https://www.ncbi.nlm.nih.gov/pubmed/33664810
http://dx.doi.org/10.3892/ol.2021.12507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882886/
https://www.ncbi.nlm.nih.gov/pubmed/33664810
http://dx.doi.org/10.3892/ol.2021.12507

Ejemplares similares